
Organic Process Research and Development p. 739 - 743 (2014)
Update date:2022-08-10
Topics:
Pan, Jiang
Zheng, Gao-Wei
Ye, Qin
Xu, Jian-He
Ethyl 4-chloro-3-oxobutanoate (COBE) was asymmetrically reduced with Escherichia coli cells expressing a reductase (ScCR) from Streptomyces coelicolor to afford enantiopure ethyl (S)-4-chloro-3-hydroxybutanoate [(S)-CHBE], which is an important precursor for preparing the drug atorvastatin. The substrate load was fixed at 100 g/L, and the concentration of coenzyme NAD+ was limited to 0.1 mM based on cost considerations. Under these conditions, the other reaction parameters were optimized as 25 °C and pH 6.5, with a biocatalyst dose of 10 kU/L in the presence of isopropanol (1.5 equiv of COBE), which acted as a cosubstrate for regenerating NADH. The reaction was performed in a toluene-aqueous biphasic system (1:1, v/v), with agitation at the maximal linear rate of 0.88 m/s. Finally, the bioreaction was performed on a pilot scale using a 50 L thermostated stirred-tank-reactor, affording (S)-CHBE in 85.4% yield and 99.9% ee, and a total turnover number (TTN) of 6060 for the cofactor NAD+. The specific production was calculated to be 36.8 gproduct/gdcw, which is the highest value reported to date among the whole-cell-mediated processes for producing (S)-CHBE.
View More
Contact:86-516-66656369
Address:The west road of Huaihai, Xuzhou, China
website:http://www.sagechem.com
Contact:+86-571-86818502
Address:Room C1301, New Youth Plaza, 8 Jia Shan Road, Hangzhou, China
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
Taizhou volsen chemical Co., Ltd
website:http://www.volsenchem.com
Contact:+86-576-88869393
Address:Jiaojiang District, Taizhou, Zhejiang, China.
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Doi:10.1016/j.jcat.2007.02.013
(2007)Doi:10.1002/chem.200800605
(2008)Doi:10.1021/ja510135t
(2014)Doi:10.1039/d1ra02516c
(2021)Doi:10.1166/jnn.2014.9947
(2014)Doi:10.1039/c4cy01651c
(2015)